One-and-done intravenous gene editing infusion might eventually be able to cure HIV

One-and-done intravenous gene editing infusion might eventually be able to cure HIV

Philadelphia Inquirer | 
In 2014, Temple University researchers proved they could use state-of-the-art molecular scissors to cut out dormant HIV hiding in human ...
We’ve made remarkable progress developing vaccines but treatments for COVID victims remain elusive

We’ve made remarkable progress developing vaccines but treatments for COVID victims remain elusive

Philadelphia Inquirer | 
The only fully approved COVID-19 drug, the antiviral remdesivir, has shown modest benefit, at best, in hospitalized patients. Two “monoclonal ...
arginine

Myocarditis and potential heart damage caused by COVID may be biggest challenge to resuscitating college sports

Philadelphia Inquirer | 
A small but growing body of evidence shows that COVID-19 can damage the heart, sometimes fatally, even in a previously ...
b d b b af fc de XL

Oral cancer epidemic in men caused by HPV, immune system gone ‘awry’

Philadelphia Inquirer | 
[S]cientists have made headway in figuring out why HPV, the human papillomavirus, has this glaring gender bias. Men are four ...

Leukemia T-cell gene therapy shows progress, but not as effective as hoped

Philadelphia Inquirer | 
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.  Four years ago, University ...
da x

Seeing a fetus’ future ills

Philadelphia Inquirer | 
Philadelphia InquirerSeeing a fetus' future illsPhiladelphia InquirerConsider that the Human Genome Project, completed in 2003, took 13 years and cost ...
e

Researchers report a gene-therapy success

Philadelphia Inquirer | 
For a quarter of a century, gene therapy has been stymied, largely because the patient's immune system attacks the treatment ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists